Antidepressants and Anticonvulsants for Diabetic Neuropathy and Postherpetic Neuralgia

Max, 1992, Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy, New Engl J Med, 326, 1250, 10.1056/NEJM199205073261904

McQuay, 1995, Anticonvulsant drugs for management of pain, BMJ, 311, 1047, 10.1136/bmj.311.7012.1047

McQuay, 1996, A systematic review of antidepressants in neuropathic pain, Pain, 68, 217, 10.1016/S0304-3959(96)03140-5

Backonja, 1998, Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus, JAMA, 280, 1831, 10.1001/jama.280.21.1831

Jadad, 1996, Developing a database of published reports of randomised clinical trials in pain research, Pain, 66, 239, 10.1016/0304-3959(96)03033-3

Reynolds, 1993, 292

Jadad, 1996, Assessing the quality of reports of randomized clinical trials, Control Clin Trials, 17, 1, 10.1016/0197-2456(95)00134-4

Moore, 1998, A systematic review of topically-applied non-steroidal anti-inflammatory drugs, BMJ, 316, 333, 10.1136/bmj.316.7128.333

Gardner, 1986, Confidence intervals rather than P values, BMJ, 292, 746, 10.1136/bmj.292.6522.746

Cook, 1995, The number needed to treat, BMJ, 310, 452, 10.1136/bmj.310.6977.452

Max, 1987, Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood, Neurology, 37, 589, 10.1212/WNL.37.4.589

Saudek, 1977, Phenytoin in the treatment of diabetic symmetrical polyneuropathy, Clin Pharmacol Ther, 22, 196, 10.1002/cpt1977222196

Rull, 1969, Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine, Diabetologia, 5, 215, 10.1007/BF01212087

Young, 1985, Pain relief in diabetic neuropathy, Diabetic Med, 2, 363, 10.1111/j.1464-5491.1985.tb00652.x

Rowbotham, 1998, Gabapentin for the treatment of postherpetic neuralgia, JAMA, 280, 1837, 10.1001/jama.280.21.1837

Kvinesdal, 1984, Imipramine therapy of painful diabetic neuropathy, JAMA, 251, 1727, 10.1001/jama.1984.03340370059031

Sindrup, 1989, Imipramine treatment in diabetic neuropathy, Eur J Clin Pharmacol, 37, 151, 10.1007/BF00558223

Sindrup, 1990, The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms, Pain, 42, 135, 10.1016/0304-3959(90)91157-E

Sindrup, 1992, Lack of effect of mianserin on the symptoms of diabetic neuropathy, Eur J Clin Pharmacol, 43, 251, 10.1007/BF02333018

Sindrup, 1990, Clomipramine vs. desipramine vs. placebo in the treatment of diabetic neuropathy symptoms. A double-blind crossover study, Brit J Clin Pharmacol, 30, 683, 10.1111/j.1365-2125.1990.tb03836.x

Max, 1992, Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy, New Engl J Med, 326, 1250, 10.1056/NEJM199205073261904

Vrethem, 1997, A comparison of amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and non-diabetics, Clin J Pain, 13, 1, 10.1097/00002508-199712000-00009

Sindrup, 1992, The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy, Clin Pharmacol Ther, 52, 547, 10.1038/clpt.1992.183

Mendel, 1986, A trial of amitriptyline and fluphenazine in the treatment of painful diabetic neuropathy, JAMA, 255, 637, 10.1001/jama.1986.03370050079025

Gomez-Perez, 1985, Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy. A double blind cross over study, Pain, 23, 395, 10.1016/0304-3959(85)90010-7

Chadda, 1978, Double blind study of the effects of diphenylhydantoin sodium on diabetic neuropathy, J Assoc Phys India, 26, 403

Max, 1991, Efficacy of desipramine in painful diabetic neuropathy, Pain, 45, 69, 10.1016/0304-3959(91)90157-S

Max, 1988, Amitriptyline, but not lorazepam, relieves postherpetic neuralgia, Neurology, 38, 1427, 10.1212/WNL.38.9.1427

Watson, 1982, Amitriptyline versus placebo in postherpetic neuralgia, Neurology, 32, 671, 10.1212/WNL.32.6.671

Kishore-Kumar, 1990, Desipramine relieves postherpetic neuralgia, Clin Pharmacol Ther, 47, 305, 10.1038/clpt.1990.33

Moore, 1998, Size is everything—large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects, Pain, 78, 209, 10.1016/S0304-3959(98)00140-7